Targeted OncologyMCL Research Must Refocus on Sequencing, Goy SaysTargeted OncologyFor example, ZUMA-2, a phase II, multicenter, open-label study is currently evaluating the efficacy of the chimeric antigen receptor (CAR) T-cell therapy axicabtagene ci… Continue reading
CRISPR-carrying Nanoparticles Edit the GenomeBioscience TechnologyIn a new study, MIT researchers have developed nanoparticles that can deliver the CRISPR genome-editing system and specifically modify genes in mice. The team used nanoparticles to carry… Continue reading
|
Tempus Announces Latest Immunotherapy Project
Markets Insider Immunotherapy is a treatment that harnesses the power of the patient’s immune system to fight diseases such as cancer. Immunotherapy stimulates a patient’s own immune system to work harder or smarter to attack cancer cells. This therapy is part of the … |
|
Tempus Announces Latest Immunotherapy Project
P&T Community Immunotherapy is a treatment that harnesses the power of the patient’s immune system to fight diseases such as cancer. Immunotherapy stimulates a patient’s own immune system to work harder or smarter to attack cancer cells. This therapy is part of the … |
|
Stem Cells in Body Transcriptionally Distinct from Those Extracted for Study
Genetic Engineering & Biotechnology News “Not just the FACS, ma’am, not just the FACS.” These words could have come from investigators who have applied a new technique to assess gene expression in stem cells. FACS, or fluorescence-activated cell sorting, is used to remove cells from their … Difference of ExpressionGenomeWeb |
|
Tempus Announces Latest Immunotherapy Project
GlobeNewswire (press release) Immunotherapy is a treatment that harnesses the power of the patient’s immune system to fight diseases such as cancer. Immunotherapy stimulates a patient’s own immune system to work harder or smarter to attack cancer cells. This therapy is part of the … |